Latest Insider Trading
Filed: 2026-04-21
Key Insights
- Director Charles Pappis exercised 5,000 stock options at $29.18 per share on April 17, 2026, immediately followed by a sale of all 5,000 shares at $52 per share, realizing a $114,100 gain.
- The sale was executed under a Rule 10b5-1 trading plan adopted on November 20, 2025, indicating a pre-planned disposition rather than opportunistic selling based on material information.
- The significant spread between exercise price ($29.18) and sale price ($52) suggests stock appreciation of 78% since the option grant, reflecting positive market sentiment toward ACMR.
- Post-transaction beneficial ownership shows zero Class A Common Stock held directly, indicating this insider reduced equity stake to cash despite holding a director position at the company.